These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 33479538)

  • 1. Global pandemics interconnected - obesity, impaired metabolic health and COVID-19.
    Stefan N; Birkenfeld AL; Schulze MB
    Nat Rev Endocrinol; 2021 Mar; 17(3):135-149. PubMed ID: 33479538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19.
    Cordeiro A; Ribamar A; Ramalho A
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101807. PubMed ID: 34543756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives.
    Dalamaga M; Christodoulatos GS; Karampela I; Vallianou N; Apovian CM
    Curr Obes Rep; 2021 Sep; 10(3):214-243. PubMed ID: 33909265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for Covid-19 severity and fatality: a structured literature review.
    Wolff D; Nee S; Hickey NS; Marschollek M
    Infection; 2021 Feb; 49(1):15-28. PubMed ID: 32860214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care.
    Pillon NJ; Loos RJF; Marshall SM; Zierath JR
    Cell; 2021 Mar; 184(6):1530-1544. PubMed ID: 33675692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with Severe Obesity during the COVID-19 Pandemic: How to Maintain an Adequate Multidisciplinary Nutritional Rehabilitation Program?
    De Amicis R; Cancello R; Capodaglio P; Gobbi M; Brunani A; Gilardini L; Castenuovo G; Molinari E; Barbieri V; Mambrini SP; Battezzati A; Bertoli S
    Obes Facts; 2021; 14(2):205-213. PubMed ID: 33744894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of obesity on COVID-19 patients.
    Yu W; Rohli KE; Yang S; Jia P
    J Diabetes Complications; 2021 Mar; 35(3):107817. PubMed ID: 33358523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention.
    Sharma JR; Yadav UCS
    Obes Res Clin Pract; 2021; 15(2):163-171. PubMed ID: 33509701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease-2019.
    Fishkin T; Goldberg MD; Frishman WH
    Cardiol Rev; 2021 Nov-Dec 01; 29(6):292-295. PubMed ID: 34261900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When Pandemics Collide: the Interplay of Obesity and COVID-19.
    Mundi MS; Patel JJ; Mohamed Elfadil O; Patel J; Patel I; Nanda S; Hurt RT
    Curr Gastroenterol Rep; 2021 Nov; 23(12):26. PubMed ID: 34735631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities.
    Yan T; Xiao R; Wang N; Shang R; Lin G
    Theranostics; 2021; 11(17):8234-8253. PubMed ID: 34373739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and COVID-19 Pandemics: Epidemiology, Mechanisms, and Management.
    Yang Y; Song Y; Hou D
    Diabetes Metab Syndr Obes; 2023; 16():4147-4156. PubMed ID: 38145256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes.
    Bigdelou B; Sepand MR; Najafikhoshnoo S; Negrete JAT; Sharaf M; Ho JQ; Sullivan I; Chauhan P; Etter M; Shekarian T; Liang O; Hutter G; Esfandiarpour R; Zanganeh S
    Front Immunol; 2022; 13():890517. PubMed ID: 35711466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota in a population highly affected by obesity and type 2 diabetes and susceptibility to COVID-19.
    García-Mena J; Corona-Cervantes K; Cuervo-Zanatta D; Benitez-Guerrero T; Vélez-Ixta JM; Zavala-Torres NG; Villalobos-Flores LE; Hernández-Quiroz F; Perez-Cruz C; Murugesan S; Bastida-González FG; Zárate-Segura PB
    World J Gastroenterol; 2021 Nov; 27(41):7065-7079. PubMed ID: 34887628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Metabolic Risk Factors on COVID-19 Clinical Outcomes: An Extensive Review.
    Azevedo RB; Wandermurem DCR; Libório FCF; Machado MK; Ushijima NM; Narde RS; D Pecly IM; Muxfeldt ES
    Curr Cardiol Rev; 2022; 18(6):e090522204452. PubMed ID: 35579126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and obesity: the meeting of two pandemics.
    Brandão SCS; Godoi ETAM; de Oliveira Cordeiro LH; Bezerra CS; de Oliveira Xavier Ramos J; de Arruda GFA; Lins EM
    Arch Endocrinol Metab; 2021 Nov; 65(1):3-13. PubMed ID: 33320454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospect of potential intrauterine programming impacts associated with COVID-19.
    Khanal P; Duttaroy AK
    Front Public Health; 2022; 10():986162. PubMed ID: 36091565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and COVID-19: A jigsaw puzzle with still missing pieces.
    Michalakis K; Panagiotou G; Ilias I; Pazaitou-Panayiotou K
    Clin Obes; 2021 Feb; 11(1):e12420. PubMed ID: 33073512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and the liver: overview.
    Amin M
    Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):309-311. PubMed ID: 32558697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [COVID-19 patients in Germany: exposure risks and associated factors for hospitalization and severe disease].
    Koppe U; Wilking H; Harder T; Haas W; Rexroth U; Hamouda O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Sep; 64(9):1107-1115. PubMed ID: 34327540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.